Literature DB >> 21459825

Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration.

Michael C Kruer1, Mark Hiken, Allison Gregory, Alessandro Malandrini, David Clark, Penny Hogarth, Marjorie Grafe, Susan J Hayflick, Randall L Woltjer.   

Abstract

Pantothenate kinase-associated neurodegeneration is a form of neurodegeneration with brain iron accumulation, characterized by a progressive movement disorder and prominent iron deposition in the globus pallidus. Formerly referred to as Hallervorden-Spatz syndrome, the disorder was renamed pantothenate kinase-associated neurodegeneration after discovery of the causative gene, PANK2. Although the pathological features of clinically characterized Hallervorden-Spatz syndrome have been described, the literature is confounded by the historical use of this term for nearly all conditions with prominent basal ganglia iron accumulation and by the fact that this term encompasses a genetically heterogeneous group of disorders, now referred to as 'neurodegeneration with brain iron accumulation'. As a result, interpreting reports that precede molecular characterization of specific forms of neurodegeneration with brain iron accumulation is problematic. In the present studies, we describe neuropathological findings in six cases of molecularly confirmed pantothenate kinase-associated neurodegeneration. We identify prominent ubiquinated deposits in pantothenate kinase-associated neurodegeneration. We also characterize two distinct origins of spheroid bodies and delineate histological features of iron deposition. In so doing, we characterize fundamental features of the disease and redefine its nosological relationship to other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459825      PMCID: PMC3105492          DOI: 10.1093/brain/awr042

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  32 in total

Review 1.  Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.

Authors:  Y Saito; M Kawai; K Inoue; R Sasaki; H Arai; E Nanba; S Kuzuhara; Y Ihara; I Kanazawa; S Murayama
Journal:  J Neurol Sci       Date:  2000-08-01       Impact factor: 3.181

2.  Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy.

Authors:  O Kitis; H Tekgul; G Erdemir; M Polat; G Serdaroglu; A Tosun; M Coker; S Gokben
Journal:  J Neuroradiol       Date:  2006-04       Impact factor: 3.447

3.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

4.  Hallervorden-Spatz syndrome.

Authors:  E C Dooling; W C Schoene; E P Richardson
Journal:  Arch Neurol       Date:  1974-01

5.  Julius Hallervorden's wartime activities: implications for science under dictatorship.

Authors:  M I Shevell; J Peiffer
Journal:  Pediatr Neurol       Date:  2001-08       Impact factor: 3.372

6.  Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology.

Authors:  K Wakabayashi; T Fukushima; R Koide; Y Horikawa; M Hasegawa; Y Watanabe; T Noda; I Eguchi; T Morita; M Yoshimoto; T Iwatsubo; H Takahashi
Journal:  Acta Neuropathol       Date:  2000-03       Impact factor: 17.088

7.  Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.

Authors:  M Neumann; S Adler; O Schlüter; E Kremmer; R Benecke; H A Kretzschmar
Journal:  Acta Neuropathol       Date:  2000-11       Impact factor: 17.088

8.  Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.

Authors:  Monique A Johnson; Yien Ming Kuo; Shawn K Westaway; Susan M Parker; Katherine H L Ching; Jane Gitschier; Susan J Hayflick
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

9.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

Authors:  Konstanze Hörtnagel; Holger Prokisch; Thomas Meitinger
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

10.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Authors:  Susan J Hayflick; Shawn K Westaway; Barbara Levinson; Bing Zhou; Monique A Johnson; Katherine H L Ching; Jane Gitschier
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

View more
  47 in total

1.  Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging.

Authors:  Sen Guo; Liu Yang; Huijie Liu; Wei Chen; Jinchen Li; Ping Yu; Zhong Sheng Sun; Xiang Chen; Jie Du; Tao Cai
Journal:  Mol Neurobiol       Date:  2016-07-09       Impact factor: 5.590

Review 2.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 3.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

4.  New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

Authors:  Penelope Hogarth; Allison Gregory; Michael C Kruer; Lynn Sanford; Wendy Wagoner; Marvin R Natowicz; Robert T Egel; S H Subramony; Jennifer G Goldman; Elizabeth Berry-Kravis; Nicola C Foulds; Simon R Hammans; Isabelle Desguerre; Diana Rodriguez; Callum Wilson; Andrea Diedrich; Sarah Green; Huong Tran; Lindsay Reese; Randall L Woltjer; Susan J Hayflick
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

Review 5.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

6.  Is Pallido-Pyramidal Syndrome Still a Useful Concept? No.

Authors:  Hugo Morales-Briceño; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2019-10-14

Review 7.  Defective pantothenate metabolism and neurodegeneration.

Authors:  Susan J Hayflick
Journal:  Biochem Soc Trans       Date:  2014-08       Impact factor: 5.407

8.  Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.

Authors:  J-H Lee; A Gregory; P Hogarth; C Rogers; S J Hayflick
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 9.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

10.  β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.

Authors:  Susan J Hayflick; Michael C Kruer; Allison Gregory; Tobias B Haack; Manju A Kurian; Henry H Houlden; James Anderson; Nathalie Boddaert; Lynn Sanford; Sami I Harik; Vasuki H Dandu; Nardo Nardocci; Giovanna Zorzi; Todd Dunaway; Mark Tarnopolsky; Steven Skinner; Kenton R Holden; Steven Frucht; Era Hanspal; Connie Schrander-Stumpel; Cyril Mignot; Delphine Héron; Dawn E Saunders; Margaret Kaminska; Jean-Pierre Lin; Karine Lascelles; Stephan M Cuno; Esther Meyer; Barbara Garavaglia; Kailash Bhatia; Rajith de Silva; Sarah Crisp; Peter Lunt; Martyn Carey; John Hardy; Thomas Meitinger; Holger Prokisch; Penelope Hogarth
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.